Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Hackensack Meridian Health
Hoffmann-La Roche
Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine
University of Nebraska
City of Hope Medical Center
Merck Sharp & Dohme LLC
University of California, Irvine
H. Lee Moffitt Cancer Center and Research Institute
Providence Health & Services
Rutgers, The State University of New Jersey
Ethicon, Inc.
EMD Serono
National Cancer Institute (NCI)
Big Ten Cancer Research Consortium
University of Kansas Medical Center
Exelixis
Pfizer
University of Massachusetts, Worcester
Eli Lilly and Company
Varian, a Siemens Healthineers Company
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
NantCell, Inc.
Mayo Clinic
Ethicon, Inc.
AstraZeneca
Hackensack Meridian Health
Brigham and Women's Hospital
Pfizer
Mayo Clinic
City of Hope Medical Center
University of Kentucky
Tempus AI
Swiss Cancer Institute
National Cancer Institute (NCI)
Amgen
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
BeiGene
Sanofi
Abramson Cancer Center at Penn Medicine
Incyte Corporation